Search Results - "MUIR, K. W."

Systematic Review of Methods for Assessing Leptomeningeal Collateral Flow by MCVERRY, F, LIEBESKIND, D. S, MUIR, K. W

“…The importance of LMF in the outcome after acute ischemic stroke is increasingly recognized, but imaging presents a wide range of options for identification of…”
Get full text

Early carotid endarterectomy following thrombolysis in the hyperacute treatment of stroke by Crozier, J. E. M., Reid, J., Welch, G. H., Muir, K. W., Stuart, W. P.

“…Background: Thrombolysis with intravenous recombinant tissue plasminogen activator improves the probability of complete neurological recovery if given promptly…”
Get full text

Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence by Sleath, B., Carpenter, D. M., Blalock, S. J., Sayner, R., Muir, K. W., Slota, C., Giangiacomo, A. L., Hartnett, M. E., Tudor, G., Robin, A. L.

“…Little is known about how ophthalmologist-patient communication over time is associated with glaucoma patient long-term adherence. The purpose of our study was…”
Get full text

Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis by Katsanos, A. H., Alexandrov, A. V., Mandava, P., Köhrmann, M., Soinne, L., Barreto, A. D., Sharma, V. K., Mikulik, R., Muir, K. W., Rothlisberger, T., Grotta, J. C., Levi, C. R., Molina, C. A., Saqqur, M., Palaiodimou, L., Psaltopoulou, T., Vosko, M. R., Moreira, T., Fiebach, J. B., Rubiera, M., Sandset, E. C., Havenon, A., Kent, T. A., Alexandrov, A. W., Schellinger, P. D., Tsivgoulis, G.

“…Background and purpose Blood pressure (BP) variability has been associated with worse neurological outcomes in acute ischaemic stroke (AIS) patients receiving…”
Get full text

The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland by Razvi, S S M, Davidson, R, Bone, I, Muir, K W

“…Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is caused by mutations of the Notch3 gene on…”
Get full text

Effect of atrial fibrillation on endovascular thrombectomy for acute ischemic stroke. A meta-analysis of individual patient data from six randomised trials: Results from the HERMES collaboration by Smaal, JA, de Ridder, IR, Heshmatollah, A, van Zwam, WH, Dippel, DWJ, Majoie, CB, Brown, S, Goyal, M, Campbell, BCV, Muir, KW, Demchuck, AM, Davalos, A, Jovin, TG, Mitchell, PJ, White, P, Saver, JL, Hill, MD, Roos, YB, van der Lugt, A, van Oostenbrugge, RJ

“…Background Atrial fibrillation is an important risk factor for ischemic stroke, and is associated with an increased risk of poor outcome after ischemic stroke…”
Get full text

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial by Muir, K W, Lees, K R, Ford, I, Davis, S

“…Magnesium is neuroprotective in animal models of stroke, and findings of small clinical pilot trials suggest potential benefit in people. We aimed to test…”
Get full text

Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register by Lees, K.R., Ford, G.A., Muir, K.W., Ahmed, N., Dyker, A.G., Atula, S., Kalra, L., Warburton, E.A., Baron, J.-C., Jenkinson, D.F., Wahlgren, N.G., Walters, M.R.

“…Aim: To describe the United Kingdom (UK) experience with thrombolytic therapy with intravenous alteplase (rt-PA) for stroke, as captured by the Implementation…”
Get full text

Atherosclerotic Carotid Plaque Composition: A 3T and 7T MRI-Histology Correlation Study by Lopez Gonzalez, M.R., Foo, S.Y., Holmes, W.M., Stewart, W., Muir, K.W., Condon, B., Welch, G., Forbes, K.P.

“…ABSTRACT BACKGROUND AND PURPOSE Carotid artery atherosclerotic plaque composition may influence plaque stability and risk of thromboembolic events, and…”
Get full text

C-reactive protein and outcome after ischemic Stroke by MUIR, K. W, WEIR, C. J, ALWAN, W, SQUIRE, L. B, LEES, K. R

“…Elevated concentrations of the acute-phase reactant C-reactive protein (CRP) predict ischemic cardiac events in both hospital- and population-based studies and…”
Get full text

Clinical experience with excitatory amino acid antagonist drugs by MUIR, K. W, LEES, K. R

“…Excitotoxic damage due to excess release of neuronal glutamate is hypothesized to play a pivotal role in the pathogenesis of focal cerebral ischemia. Drugs…”
Get full text

Health literacy and vision-related quality of life by Muir, K W, Santiago-Turla, C, Stinnett, S S, Herndon, L W, Allingham, R R, Challa, P, Lee, P P

“…Non-visual factors influence a person's vision-related quality of life (VRQoL). The purpose of this study was to assess the relationship between health…”
Get more information

Changing clinical patterns and increasing prevalence in CADASIL by Moreton, F. C., Razvi, S. S. M., Davidson, R., Muir, K. W.

“…Objectives CADASIL is a monogenic small vessel vasculopathy causing recurrent stroke. Early descriptions suggested dementia and disability were common from the…”
Get full text

Brain imaging factors associated with progression of subcortical hyperintensities in CADASIL over 2‐year follow‐up by Moreton, F. C., Cullen, B., Dickie, D. A., Lopez Gonzalez, R., Santosh, C., Delles, C., Muir, K. W.

“…Cerebral blood flow declined in a cohort of CADASIL patients, as measured with arterial spin labelling MRI over two years. Lower cerebral blood flow at…”
Get full text

Is inadequate family history a barrier to diagnosis in CADASIL? by Razvi, S. S. M., Davidson, R., Bone, I., Muir, K. W.

“…Objectives –  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) has typical clinical features that include…”
Get full text

Comparison of neurological scales and scoring systems for acute stroke prognosis by MUIR, K. W, WEIR, C. J, MURRAY, G. D, POVEY, C, LEES, K. R

“…Clinical trials routinely use stroke scales to compare baseline characteristics of treatment groups. It is unclear which stroke scale provides the most…”
Get full text

Magnesium in stroke treatment by Muir, K W

“…Magnesium is involved in multiple physiological processes that may be relevant to cerebral ischaemia, including antagonism of glutamate release, NMDA receptor…”
Get full text

Visual evaluation of perfusion computed tomography in acute stroke accurately estimates infarct volume and tissue viability by Muir, K W, Halbert, H M, Baird, T A, McCormick, M, Teasdale, E

“…Objective: To establish the validity of visual interpretation of immediately processed perfusion computed tomography (CT) maps in acute stroke for prediction…”
Get full text

Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage by McCarron, M. O., Weir, C. J., Muir, K. W., Hoffmann, K. L., Graffagnino, C., Nicoll, J. A. R., Lees, K. R., Alberts, M. J.

“…Objective– To determine the relationship between the apolipoprotein E (APOE) ε4 allele and in‐hospital mortality from intracerebral haemorrhage (ICH). Material…”
Get full text

Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists by Muir, Keith W

“…The majority of clinical trials of N-methyl d-aspartate antagonists have been conducted in the fields of stroke, traumatic brain injury (TBI) and dementia…”
Get full text